Plasma methylated GNB4 and Riplet as a novel dual-marker panel for the detection of hepatocellular carcinoma-Reference-Cited by-同舟云学术

Plasma methylated GNB4 and Riplet as a novel dual-marker panel for the detection of hepatocellular carcinoma

Published:2023-12-28 Issue:1 Volume:19 Page:
ISSN:1559-2294
Container-title:Epigenetics
language:en
Short-container-title:Epigenetics

Author:

Zhao Yanteng¹,Zhao Lei²,Jin Huifang¹,Xie Ying¹,Chen Liyinghui¹,Zhang Wei³,Dong Lanlan³,Zhang Lianglu³,Huang Yue³,Wan Kangkang³,Yang Qiankun¹,Wang Shaochi⁴

Affiliation:

1. Department of Transfusion, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China

2. Plastic maxillofacial surgery, Jiangxi Provincial People’s Hospital, Nanchang, Jiangxi, China

3. Research and development department, Wuhan Ammunition Life-tech Company, Ltd., Wuhan, Hubei, China

4. Translational Medicine Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China

Funder

the Henan Provincial Science and Technology Research Project

Publisher

Informa UK Limited

Subject

Cancer Research,Molecular Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/15592294.2023.2299044

Reference45 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Attributable deaths of liver cancer in China

3. Identification of CDCA2 as a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma

4. A global view of hepatocellular carcinoma: trends, risk, prevention and management

5. The therapeutic landscape of hepatocellular carcinoma

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma;Molecular Cancer;2024-09-06

2. A dual-gene panel of two fragments of methylated IRF4 and one of ZEB2 in plasma cell-free DNA for gastric cancer detection;Epigenetics;2024-07-14

3. Clinical potential of serum prostaglandin A2 as a novel diagnostic biomarker for hepatocellular cancer;Clinica Chimica Acta;2024-07

4. Methylated circulating tumor DNA in hepatocellular carcinoma: A comprehensive analysis of biomarker potential and clinical implications;Cancer Treatment Reviews;2024-07

5. Research Progress on the Role of Epigenetic Methylation Modification in Hepatocellular Carcinoma;Journal of Hepatocellular Carcinoma;2024-06